Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Apyx Medical Corp. (APYX) Reports In-Line Q1 EPS, Revenues Beat; Offers 2Q Revenues Outlook
May 12, 2021 7:13 AM EDTApyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $7.84 million.
First Quarter 2021 Financial Summary:
Total revenue of $8.6 million, up 72.9% year-over-year.Advanced Energy revenue of $7.7 million, up 92.2% year-over-year.OEM revenue of $1.0 million, down 3.3% year-over-year.Net loss of $4.9 million, compared to net loss of $2.0 million for the first quarter of 2020. Net loss in the first quarter of 2020 included an income tax benefit of $4.9 million.Adjusted EBITDA... More